KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Cost of Revenue (2016 - 2025)

Cme (CME) has disclosed Cost of Revenue for 17 consecutive years, with $85.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 4.98% to $85.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $248.5 million, a 7.14% decrease, with the full-year FY2025 number at $248.5 million, down 7.14% from a year prior.
  • Cost of Revenue was $85.9 million for Q4 2025 at Cme, up from $55.1 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $101.9 million in Q4 2023 to a low of $43.9 million in Q3 2022.
  • A 5-year average of $63.7 million and a median of $56.6 million in 2023 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: crashed 30.58% in 2021, then grew 28.7% in 2023.
  • Cme's Cost of Revenue stood at $80.9 million in 2021, then grew by 17.43% to $95.0 million in 2022, then increased by 7.26% to $101.9 million in 2023, then fell by 11.29% to $90.4 million in 2024, then fell by 4.98% to $85.9 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Cost of Revenue are $85.9 million (Q4 2025), $55.1 million (Q3 2025), and $53.2 million (Q2 2025).